Ullrich Mayeski, community engagement director of health with GS1 US, explains how with over a decade of collaboration, ...
The South Korean pharma company’s US subsidiary is purchasing Eli Lilly’s Branchburg, NJ site to safeguard against potential ...
This episode of Pharma Pulse covers ACIP’s move toward shared decision-making for COVID-19 vaccines, Pfizer’s acquisition of ...
Ullrich Mayeski, community engagement director of health with GS1 US, describes of the organization’s EPCIS standard for meeting DSCSA requirements while underscoring that true supply chain success ...
Closed Loop Medicine Debuts WeDosify in US to Personalize GLP-1 Dosing and Improve Patient Adherence
The platform enables clinicians to tailor GLP-1 titration at scale, aiming to reduce discontinuation rates and improve ...
This episode of Pharma Pulse covers the CDC’s decision to postpone changes to Hepatitis B vaccine guidance, new research ...
Takeda will be shipping treatments between Europe and the US using VELA’s sailing cargo trimaran, potentially reducing ...
Industry leaders—from manufacturers, distributors, and dispensers—reported increased preparedness for compliance, with discussions shifting toward exception management, governance, and enforcement ...
New bipartisan legislation would give the FDA authority to modernize prescribing information, reducing waste while improving ...
This episode of Pharma Pulse covers GSK’s $30 billion plan to expand US biopharma production, new evidence that weekly GLP-1 therapies significantly reduce cardiovascular risks, and Roche’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback